Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells

BACKGROUND: Numerous studies have implicated the aryl hydrocarbon receptor (AhR) as a potential therapeutic target for several human diseases, including estrogen receptor alpha (ERα) positive breast cancer. Aminoflavone (AF), an activator of AhR signaling, is currently undergoing clinical evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkman, Ashley M, Wu, Jiacai, Ersland, Karen, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037283/
https://www.ncbi.nlm.nih.gov/pubmed/24885022
http://dx.doi.org/10.1186/1471-2407-14-344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037283/
https://www.ncbi.nlm.nih.gov/pubmed/24885022
http://dx.doi.org/10.1186/1471-2407-14-344

Ejemplares similares